Device Management in Heart Failure

Overview

Journal Curr Cardiol Rep

Publisher Current Science

Specialty Cardiology & Vascular Diseases

Date 2017 Sep 27

PMID 28948481

Citations 1

Authors

Brett G Angel

Heath Saltzman

Luke S Kusmirek

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: Medical devices have become an integral part of comprehensive heart failure management. Not all heart failure patients, however, accrue benefit from every new device, and even with extensive practice guidelines, this remains an evolving field.

Recent Findings: The addition of implantable devices, like internal cardioverter defibrillators (ICDs), and novel pacing technologies, including cardiac resynchronization therapy (CRT), have helped to compliment goal-directed medical therapy and positively impact prognosis in multiple high-quality clinical trials. This review attempts to summarize the rapidly evolving literature with respect to existing device guidelines for routine implantable devices as well as some available and future technologies that are not yet a part of routine guidelines. ICD, CRT, and other implantable devices continue to save lives, decrease hospitalizations, and evolve the management of patients with heart failure beyond the capabilities of optimal guideline-directed medical therapy alone.

Citing Articles

Left ventricular lead misplacement discovered a decade after cardiac resynchronization therapy-defibrillator implantation: a case report.

Leung L, Evranos B, Narain R, Gallagher M Eur Heart J Case Rep. 2019; 2(2):yty071.

PMID: 31020148 PMC: 6176968. DOI: 10.1093/ehjcr/yty071.

References

Connolly S, Gent M, Roberts R, Dorian P, Roy D, Sheldon R . Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000; 101(11):1297-302. DOI: 10.1161/01.cir.101.11.1297. View

Siebels J, Kuck K . Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). Am Heart J. 1994; 127(4 Pt 2):1139-44. DOI: 10.1016/0002-8703(94)90101-5. View

Gold M, Thebault C, Linde C, Abraham W, Gerritse B, Ghio S . Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study. Circulation. 2012; 126(7):822-9. DOI: 10.1161/CIRCULATIONAHA.112.097709. View

Swerdlow C, Chen P, Kass R, ALLARD J, Peter C . Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator. J Am Coll Cardiol. 1994; 23(6):1342-55. DOI: 10.1016/0735-1097(94)90376-x. View

Cleland J, Massie B, Packer M . Sudden death in heart failure: vascular or electrical?. Eur J Heart Fail. 2000; 1(1):41-5. DOI: 10.1016/S1388-9842(99)00009-4. View

Goldenberg I, Moss A, McNitt S, Zareba W, Hall W, Andrews M . Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol. 2006; 47(9):1811-7. DOI: 10.1016/j.jacc.2005.12.048. View

Kadish A, Dyer A, Daubert J, Quigg R, Mark Estes N, Anderson K . Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004; 350(21):2151-8. DOI: 10.1056/NEJMoa033088. View

Ehrlich J, Nattel S, Hohnloser S . Atrial fibrillation and congestive heart failure: specific considerations at the intersection of two common and important cardiac disease sets. J Cardiovasc Electrophysiol. 2002; 13(4):399-405. DOI: 10.1046/j.1540-8167.2002.00399.x. View

. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997; 337(22):1576-83. DOI: 10.1056/NEJM199711273372202. View

10.

Kuck K, Cappato R, Siebels J, Ruppel R . Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH). Circulation. 2000; 102(7):748-54. DOI: 10.1161/01.cir.102.7.748. View

11.

Friedman P, McClelland R, Bamlet W, Acosta H, Kessler D, Munger T . Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study. Circulation. 2006; 113(25):2871-9. DOI: 10.1161/CIRCULATIONAHA.105.594531. View

12.

Solomon S, Wang D, Finn P, Skali H, Zornoff L, McMurray J . Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation. 2004; 110(15):2180-3. DOI: 10.1161/01.CIR.0000144474.65922.AA. View

13.

Rinaldi C, Simon R, Baszko A, Bostock J, Elliot D, Bucknall C . A 17 year experience of inappropriate shock therapy in patients with implantable cardioverter-defibrillators: are we getting any better?. Heart. 2004; 90(3):330-1. PMC: 1768130. DOI: 10.1136/hrt.2003.026195. View

14.

Wever E, Hauer R, van Capelle F, Tijssen J, Crijns H, Algra A . Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation. 1995; 91(8):2195-203. DOI: 10.1161/01.cir.91.8.2195. View

15.

Cleland J, Daubert J, Erdmann E, Freemantle N, Gras D, Kappenberger L . The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005; 352(15):1539-49. DOI: 10.1056/NEJMoa050496. View

16.

Tanno K, Miyoshi F, Watanabe N, Minoura Y, Kawamura M, Ryu S . Are the MADIT II criteria for ICD implantation appropriate for Japanese patients?. Circ J. 2005; 69(1):19-22. DOI: 10.1253/circj.69.19. View

17.

Moss A, Zareba W, Hall W, Klein H, Wilber D, Cannom D . Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002; 346(12):877-83. DOI: 10.1056/NEJMoa013474. View

18.

Ellenbogen K, Gold M, Meyer T, Fernndez Lozano I, Mittal S, Waggoner A . Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic.... Circulation. 2010; 122(25):2660-8. DOI: 10.1161/CIRCULATIONAHA.110.992552. View

19.

Tang A, Wells G, Talajic M, Arnold M, Sheldon R, Connolly S . Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med. 2010; 363(25):2385-95. DOI: 10.1056/NEJMoa1009540. View

20.

Epstein A, Neal Kay G, Plumb V, McElderry H, Doppalapudi H, Yamada T . Implantable cardioverter-defibrillator prescription in the elderly. Heart Rhythm. 2009; 6(8):1136-43. DOI: 10.1016/j.hrthm.2009.04.010. View